Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App





New Algorithm for Rapid, Automated Diagnosis of COVID-19 from Chest CTs Overcomes RT-PCR Limitations

By HospiMedica International staff writers
Posted on 25 Oct 2021

Scientists have developed a new algorithm for rapid, computerized diagnosis of COVID-19 that overcomes the limitations of reverse transcription polymerase chain reaction. More...

The new framework for accurate and interpretable automated analysis of chest CT scans was developed by researchers at the Daegu Gyeongbuk Institute of Science (DGIST; Daegu, South Korea). The current standard for diagnosis of COVID-19 through reverse transcription polymerase chain reaction (RT-PCR) is limited owing to its low sensitivity, high rate of false positives, and long testing times. This makes it difficult to identify infected patients quickly and provide them with treatment. Furthermore, there is a risk that patients will still spread the disease while waiting for the results of their diagnostic test.

Chest CT scans have emerged as a quick and effective way to diagnose the disease, but they require radiologist expertise to interpret, and sometimes the scans look similar to other kinds of lung infections, like bacterial pneumonia. Now, a team of scientists have developed a technique for the automated and accurate interpretation of chest CT scans. To build their diagnostic framework, the research team used a Machine Learning technique called “Multiple Instance Learning” (MIL). In MIL, the machine learning algorithm is “trained” using sets, or “bags,” of multiple examples called “instances.” The MIL algorithm then uses these bags to learn to label individual examples or inputs.

The research team trained their new framework, called dual attention contrastive based MIL (DA-CMIL), to differentiate between COVID and bacterial pneumonia, and found that its performance was on par to other state-of-the-art automated image analysis methods. Moreover, the DA-CMIL algorithm can leverage limited or incomplete information to efficiently train its AI system. This research extends far beyond the COVID pandemic, laying the foundation for the development of more robust and cheap diagnostic systems, which will be of particular benefit to under-developed countries or countries with otherwise limited medical and human resources.

“Our study can be viewed from both a technical and clinical perspective. First, the algorithms introduced here can be extended to similar settings with other types of medical images. Second, the ‘dual attention,’ particularly the ‘spatial attention,’ used in the model improves the interpretability of the algorithm, which will help clinicians understand how automated solutions make decisions,” explained Prof. Sang Hyun Park and Philip Chikontwe from DGIST, who led the study.

Related Links:
Daegu Gyeongbuk Institute of Science (DGIST)


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.